Phenylpropanolamine
 |
|
 |
|
| Clinical data | |
|---|---|
| Trade names | Acutrim |
| AHFS/Drugs.com | Multum Consumer Information |
| Routes of administration |
Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic (CYP2D6) |
| Biological half-life | 2.1–3.4 hours |
| Identifiers | |
|
|
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| ECHA InfoCard | 100.035.349 |
| Chemical and physical data | |
| Formula | C9H13NO |
| Molar mass | 151.206 g/mol |
| 3D model (Jmol) | |
|
|
|
|
Phenylpropanolamine (BAN and INN; PPA, β-hydroxyamphetamine), also known as the stereoisomers norephedrine, norpseudoephedrine, and cathine, is a psychoactive drug of the phenethylamine and amphetamine chemical classes which is used as a stimulant, decongestant, and anorectic agent. It is commonly used in prescription and over-the-counter cough and cold preparations. In veterinary medicine, it is used to control urinary incontinence in dogs under trade names Propalin and Proin.
In the United States, PPA is no longer sold due to a purported increased risk of stroke in younger women. In a few countries in Europe, however, it is still available either by prescription or sometimes over-the-counter. In Canada, it was withdrawn from the market on 31 May 2001. In India human use of PPA and its formulations was banned on 10 February 2011, but the ban was overturned by the judiciary in September 2011.
Phenylpropanolamine acts as an alpha-adrenergic receptor and beta-adrenergic receptor agonist as well as a dopamine receptor D1 partial agonist.
...
Wikipedia